![Craig Millian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Millian
Directeur Général chez
HLS THERAPEUTICS INC.
Fortune : 43 500 $ au 30/06/2026
Profil
Craig Millian is currently Chief Executive Officer & Director at HLS Therapeutics, Inc. since 2023.
Former roles include Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023, Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018, Vice President-Commercial at Vertex Pharmaceuticals, Inc., and a position at EMD Serono, Inc. from 2012 to 2018.
Education includes an undergraduate degree from the University of Pennsylvania and an MBA from New York University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HLS THERAPEUTICS, INC. 0,05 % | 26/06/2026 | 14 500 ( 0,05 % ) | 43 500 $ | 30/06/2026 |
Postes actifs de Craig Millian
| Sociétés | Poste | Début |
|---|---|---|
| HLS THERAPEUTICS INC. | Directeur Général | 01/05/2023 |
Anciens postes connus de Craig Millian
| Sociétés | Poste | Fin |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur des opérations | 14/04/2023 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/12/2018 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Formation de Craig Millian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
